Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Finding and Funding the Cure for Alzheimer’s Disease

Posted by Ed Schoonveld on Wed, Apr 29, 2015

Alzheimer’s disease (AD) is projected to become a major drain on global health-care systems, with the cost of care for the United States alone amounting to more than $214 billion in 2014 and estimated to grow to $1.2 trillion annually by 2050.1 With limited treatment options, the disease is putting a large and growing humanistic toll on patients and their families. Research efforts have so far been disappointing, as a large number of developmental agents have failed to demonstrate efficacy in reducing symptoms or, preferably, alter progression of the disease. The recent news of positive early stage trial results for Biogen’s aducanumab has renewed hope for effective solutions for this devastating disease. However, many challenges remain in finding and funding new treatments.

Read More

Topics: Ed Schoonveld, Pharmaceutical Pricing, Market Access, Alzheimer's Disease

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.